What are the guidelines for using Benadryl (diphenhydramine) in infants?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benadryl (Diphenhydramine) Should Not Be Used in Infants

Diphenhydramine is contraindicated in infants under 6 years of age according to FDA labeling, and should be avoided in neonates due to significant risks of respiratory depression, sedation, paradoxical agitation, and potential seizures. 1, 2

FDA-Approved Age Restrictions

  • The FDA explicitly states "Do not use" for children under 6 years of age for over-the-counter diphenhydramine products 1
  • This represents the clearest regulatory guidance against using this medication in the infant population
  • The approved dosing begins only at age 6 years and older (10 mL or 25 mg for children 6 to under 12 years) 1

Specific Risks in Neonates and Infants

Neonates face particularly severe adverse effects including:

  • Respiratory suppression and sedation 2
  • Hypotension 2
  • Paradoxical excitement or agitation 2
  • Risk of seizures, especially with rapid IV administration 2
  • Documented cases of severe toxicity and death in young children, including from topical application 3

Lack of Pediatric Emergency Guidelines

  • The American Academy of Pediatrics does not include specific dosing recommendations for diphenhydramine in neonates in their pediatric emergency medication guidelines 2, 4
  • While pediatric guidelines mention diphenhydramine for acute hypersensitivity reactions at 1-2 mg/kg IV/IM (maximum 50 mg), these recommendations are not specific to neonates and should not be extrapolated to this age group 2

Safer Alternatives for Allergic Reactions

For allergic reactions in infants requiring intervention:

  • Epinephrine remains the first-line treatment for severe allergic reactions, with appropriate neonatal dosing of 0.01-0.03 mg/kg of 1:10,000 solution 2
  • Consultation with a pediatric allergist or emergency medicine specialist is strongly recommended before administering any antihistamine to a neonate 2
  • Second-generation antihistamines have better safety profiles in older children, though data in infants remain limited 4, 5

Additional Safety Concerns

Diphenhydramine carries multiple warnings even in approved age groups:

  • Should not be used "to make a child sleepy" 1
  • Can cause marked drowsiness and excitability, especially in children 1
  • Risk of respiratory problems in patients with chronic bronchitis 1
  • Documented case of severe neonatal depression from maternal ingestion before delivery 6

Toxicity Thresholds

If accidental ingestion occurs:

  • Children less than 6 years of age who ingest at least 7.5 mg/kg of diphenhydramine should be referred to an emergency department 7
  • Close monitoring for respiratory depression, hypotension, and neurological effects is essential if diphenhydramine must be administered in emergency situations 2
  • Do not induce emesis due to potential for rapid loss of consciousness or seizures 7

Clinical Bottom Line

There is no safe or FDA-approved indication for diphenhydramine use in infants. The combination of explicit FDA contraindication, lack of neonatal-specific guidelines from major pediatric organizations, documented cases of severe toxicity, and availability of safer alternatives makes diphenhydramine an inappropriate choice for this age group. 1, 2, 3, 5

References

Guideline

Safety of Diphenhydramine in Neonates

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Death of a child from topical diphenhydramine.

The American journal of forensic medicine and pathology, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diphenhydramine: Time to Move on?

The journal of allergy and clinical immunology. In practice, 2022

Research

Diphenhydramine toxicity in a newborn: a case report.

Journal of perinatology : official journal of the California Perinatal Association, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.